~ Announces Initial Common Stock Quarterly Dividend of $0.25 Per Share and New Stock Repurchase Program ~
First Quarter Fiscal Year 2026
Consolidated net sales increased...
Net Revenues of $1.254 billion, Up 6.6% (6.2% constant currency)1Data-Tech-AI Net Revenues of $599 million, Up 9.7% (9.5% constant currency)1Digital Operations Net Revenues of...
Second quarter revenue of $1.043 billion, up 7% year-over-year and up 6% when adjusted for foreign exchange*
Cloud Infrastructure Services** revenue of $71 million, up 30% year-over-year...
GROSSE POINTE FARMS, Mich., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Saga Communications, Inc. (Nasdaq - SGA) (the “Company” or “Saga”) today reported that net revenue decreased 5.0% to $28.2 million for the quarter ended June 30, 2025 compared to $29.7 million for the same period last year. Station operating expense decreased 4.6% for the quarter to $22.2 million compared to the same period last year. For the quarter, operating income was $1.4 million compared to $2.1 million for the same quarter last year and station operating income (a non-GAAP financial measure) decreased 6.4% to $6.0 million. Capital expenditures were $1.3 million for the quarter compared to $1.5 million for the same period last year. We had net income of $1.1 million for the quarter compared to net income of $2.5 million for the second quarter last year. Diluted earnings per share were $0.18 in the second quarter of 2025.
Financial and Business Highlights
Service revenue was $246.2 million for Q2 2025 and was $247.0 million for Q1 2025.Wavelength revenue increased by 27.2%, sequentially, and...
ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.
Revises full year 2025 Net Sales, Adjusted EBITDA, and Adjusted Free Cash Flow guidanceReaffirms cost synergy capture targets of $200 million in 2025; $300...
Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of 2025
Initiated ALKAZAR...
WAYNE, Pa., Aug. 7, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading integrated and innovative global provider of advanced...
SINGAPORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) reports its unaudited financial and operating results for the three and six month periods ended June 30, 2025.